Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Public ClinicalTrials.gov record NCT02287467. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study (INSIGHT 006: FLU-IVIG)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Influenza (the flu) is a common illness that usually occurs in autumn and winter. The flu is usually mild, but can cause serious illness or death. The purpose of this study is to test the safety and effectiveness of an antibody against the flu (called intravenous hyperimmune immunoglobulin or IVIG) in people who are hospitalized for severe flu.
Study identification
- NCT ID
- NCT02287467
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 329 participants
Conditions and interventions
Conditions
Interventions
- Intravenous hyperimmune immunoglobulin (IVIG) Biological
- Placebo for IVIG Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2015 (Type not available)
- Primary completion
- Jun 7, 2018 (Actual)
- Completion
- Jun 7, 2018 (Actual)
- Last update posted
- Nov 14, 2019
2015 – 2018
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD Antiviral Research Center (A VRC) | San Diego | California | 92103 | — |
| Denver Public Health | Denver | Colorado | 80204 | — |
| University of Illinois | Chicago | Illinois | 60612 | — |
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Minneapolis VA Medical Center | Minneapolis | Minnesota | 55417 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Cooper University Hospital | Camden | New Jersey | 08103 | — |
| Cornell CRS | New York | New York | 10010 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Case Western Reserve University | Cleveland | Ohio | 44106 | — |
| OHIO State University (OSU) Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Miami Valley Hospital | Dayton | Ohio | 45409 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75235 | — |
| West Virginia University | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02287467, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 14, 2019 · Synced Nov 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02287467 live on ClinicalTrials.gov.